Logo do repositório
 
Publicação

Fármacos para tratamento da COVID-19

2020-07Recensão Acesso aberto
Ver registo simples
dc.contributor.authorMarto, Natalia
dc.contributor.authorMarto, Natália
dc.contributor.authorMonteiro, Emília C.
dc.contributor.authorMonteiro, E.C.
dc.contributor.institutionNOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
dc.contributor.institutionCentro de Estudos de Doenças Crónicas (CEDOC)
dc.contributor.pblBiblioteca Nacional de Portugal, Centro de Estudos Históricos, CELOM
dc.date.accessioned2020-07-13T22:47:56Z
dc.date.available2020-07-13T22:47:56Z
dc.date.issued2020-07
dc.description.abstractThe novel severe acute respiratory syndrome coronavirus 2 is the cause of Coronavirus Disease 2019, a new illness with no effective treatment or vaccine that has reached pandemic proportions. In this document, we analyze how health authorities and agencies around the world position themselves regarding the off-label use of repurposed drugs or new investigational drugs to treat Coronavirus Disease 2019. We review the most promising candidate medicines, including available evidence, clinical recommendations and current options for access. Our concluding remarks stress the importance of administering off-label and investigational drugs in the setting of clinical trials, or at least in standardized scenarios, to generate as much scientific knowledge as achievable while engaging in the best efforts to treat patients and save lives.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent5
dc.format.extent307080
dc.identifier.doi10.20344/AMP.13908
dc.identifier.issn0870-399X
dc.identifier.otherPURE: 18994866
dc.identifier.otherPURE UUID: aafd4461-e1b0-4c0c-a783-de5290109669
dc.identifier.otherScopus: 85087440155
dc.identifier.otherPubMed: 32425152
dc.identifier.otherWOS: 000546361300008
dc.identifier.urihttp://hdl.handle.net/10362/100823
dc.identifier.urlhttps://www.scopus.com/pages/publications/85087440155
dc.language.isopor
dc.peerreviewedyes
dc.subjectCoronavirus
dc.subjectCoronavirus Infections/drug therapy
dc.subjectCOVID-19/drug therapy
dc.subjectGeneral Medicine
dc.subjectSDG 3 - Good Health and Well-being
dc.titleFármacos para tratamento da COVID-19pt
dc.title.alternativeMedicines for the treatment of COVID-19Awaiting the evidenceen
dc.title.subtitleÀ espera da evidênciapt
dc.typereview
degois.publication.firstPage500
degois.publication.issue7-8
degois.publication.lastPage504
degois.publication.titleActa Médica Portuguesa
degois.publication.volume33
dspace.entity.typePublication
person.familyNameMarto
person.familyNameMonteiro
person.givenNameNatália
person.givenNameEmília Carreira
person.identifier.ciencia-id911A-26CD-7A4B
person.identifier.ciencia-id5918-54A6-FAA0
person.identifier.orcid0000-0003-2898-0816
person.identifier.orcid0000-0002-0570-0765
person.identifier.scopus-author-id7102113853
rcaap.rightsopenAccess
relation.isAuthorOfPublication8c02dfbf-e5df-484e-9c11-70911c54c345
relation.isAuthorOfPublication631292a4-58bc-4ec4-97ee-1143e44df2c0
relation.isAuthorOfPublication.latestForDiscovery631292a4-58bc-4ec4-97ee-1143e44df2c0

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
13908_55259_2_PB.pdf
Tamanho:
299.88 KB
Formato:
Adobe Portable Document Format
Ver/Abrir

Coleções

NMS: CEDOC - Artigos em revista nacional com arbitragem científica